Is Kiora Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: KPRX) stock is to Buy KPRX stock.
Out of 1 analyst, 0 (0%) are recommending KPRX as a Strong Buy, 1 (100%) are recommending KPRX as a Buy, 0 (0%) are recommending KPRX as a Hold, 0 (0%) are recommending KPRX as a Sell, and 0 (0%) are recommending KPRX as a Strong Sell.
What is KPRX's revenue growth forecast for 2024-2024?
(NASDAQ: KPRX) Kiora Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Kiora Pharmaceuticals's revenue in 2024 is $0.
In 2024, KPRX is forecast to generate $420,099,152 in revenue, with the lowest revenue forecast at $420,099,152 and the highest revenue forecast at $420,099,152.
What is KPRX's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: KPRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
What is KPRX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year KPRX price target, the average KPRX price target is $2.00, with the highest KPRX stock price forecast at $2.00 and the lowest KPRX stock price forecast at $2.00.
The Wall Street analyst predicted that Kiora Pharmaceuticals's share price could reach $2.00 by Mar 27, 2025. The average Kiora Pharmaceuticals stock price prediction forecasts a potential upside of 183.29% from the current KPRX share price of $0.71.
What is KPRX's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: KPRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.